|
Jun 30
|
The 5 Most Interesting Analyst Questions From Guardant Health’s Q1 Earnings Call
|
|
Jun 25
|
The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call
|
|
Jun 23
|
TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?
|
|
Jun 23
|
Medical Services Name Flirts With A Buy Point
|
|
Jun 20
|
Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?
|
|
Jun 18
|
Dow Jones Futures Await Trump's 'Ideas' For Iran; Powell In No Hurry
|
|
Jun 13
|
3 of Wall Street’s Favorite Stocks Facing Headwinds
|
|
May 29
|
Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers
|
|
May 28
|
Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way
|
|
May 27
|
Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test
|
|
May 23
|
New Tests Promise to Reveal the Secrets in Your Blood
|
|
May 22
|
Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting
|
|
May 21
|
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
|
|
May 21
|
Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio
|
|
May 21
|
Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors
|
|
May 20
|
Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer
|
|
Apr 17
|
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
|
|
Apr 15
|
Guardant Health price target raised to $60 from $56 at BofA
|
|
Apr 3
|
Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
|
|
Apr 1
|
3 Small-Cap Stocks in the Doghouse
|